A multicenter phase II study of gemcitabine plus S-1 chemotherapy for advanced biliary tract cancer

被引：0
|
作者：
Arima, S. [1 ]
Shimizu, K. [2 ]
Okamoto, T. [3 ]
Toki, S. [4 ]
Kasuga, A. [1 ]
Kitamura, H. [1 ]
Takasu, A. [1 ]
Nagashima, F. [1 ]
Sugiyama, M. [5 ]
Furuse, J. [1 ]
机构：
[1] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan
[2] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan
[3] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan
[4] Kyorin Univ, Sch Med, Dept Internal Med 3, Tokyo, Japan
[5] Kyorin Univ, Sch Med, Dept Surg, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2620
引用
收藏
页码：S627 / S627
页数：1
相关论文
共 50 条
  • [21] Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study
    Naminatsu Takahara
    Hiroyuki Isayama
    Yousuke Nakai
    Takashi Sasaki
    Kazunaga Ishigaki
    Kei Saito
    Dai Akiyama
    Rie Uchino
    Suguru Mizuno
    Hiroshi Yagioka
    Hirofumi Kogure
    Osamu Togawa
    Saburo Matsubara
    Yukiko Ito
    Nobuo Toda
    Minoru Tada
    Kazuhiko Koike
    Investigational New Drugs, 2017, 35 : 269 - 276
  • [22] Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study
    Takahara, Naminatsu
    Isayama, Hiroyuki
    Nakai, Yousuke
    Sasaki, Takashi
    Ishigaki, Kazunaga
    Saito, Kei
    Akiyama, Dai
    Uchino, Rie
    Mizuno, Suguru
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Togawa, Osamu
    Matsubara, Saburo
    Ito, Yukiko
    Toda, Nobuo
    Tada, Minoru
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (03) : 269 - 276
  • [23] A randomized phase II study of gemcitabine (GEM) plus S-1 combination chemotherapy versus GEM monotherapy in patients (pts) with advanced biliary tract cancer (BTC)
    Sasaki, T.
    Isayama, H.
    Ito, Y.
    Yasuda, I.
    Toda, N.
    Hanada, K.
    Matsubara, S.
    Maoguchi, H.
    Yashlma, Y.
    Kamada, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [24] PHASE II TRIAL OF GEMCITABINE AND S-1 COMBINATION FOR PATIENTS WITH ADVANCED PANCREAS AND BILIARY TRACT CANCER
    Zang, D. Y.
    Kim, J. H.
    Hwang, S. W.
    Kim, H. Y.
    Kim, H. J.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Park, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
  • [25] Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)
    Morizane, Chigusa
    Okusaka, Takuji
    Mizusawa, Junki
    Takashima, Atsuo
    Ueno, Makoto
    Ikeda, Masafumi
    Hamamoto, Yasuo
    Ishii, Hiroshi
    Boku, Narikazu
    Furuse, Junji
    CANCER SCIENCE, 2013, 104 (09): : 1211 - 1216
  • [26] Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
    Watanabe, Akinori
    Kida, Mitsuhiro
    Miyazawa, Shiro
    Iwai, Tomohisa
    Okuwaki, Kosuke
    Kaneko, Toru
    Yamauchi, Hiroshi
    Takezawa, Miyoko
    Imaizumi, Hiroshi
    Koizumi, Wasaburo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (19) : 5979 - 5984
  • [27] Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
    Chiang, Nai-Jung
    Chen, Ming-Huang
    Yang, Shih-Hung
    Hsu, Chiun
    Yen, Chia-Jui
    Tsou, Hsiao-Hui
    Su, Yung-Yeh
    Chen, Jen-Shi
    Shan, Yan-Shen
    Chen, Li-Tzong
    LIVER INTERNATIONAL, 2020, 40 (10) : 2535 - 2543
  • [28] Gemcitabine and cisplatin plus immunotherapy in advanced biliary tract cancer: a phase II study
    不详
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (5) : 280 - 280
  • [29] Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer
    Hosoda, Kiyotaka
    Fukushima, Kentaro
    Shimizu, Akira
    Motoyama, Hiroaki
    Kubota, Koji
    Notake, Tsuyoshi
    Sugenoya, Shinsuke
    Hayashi, Hikaru
    Yasukawa, Koya
    Kobayashi, Ryoichiro
    Soejima, Yuji
    ONCOLOGY, 2021, 99 (11) : 703 - 712
  • [30] Gemcitabine and cisplatin plus immunotherapy in advanced biliary tract cancer: a phase II study
    Jordan Hindson
    Nature Reviews Gastroenterology & Hepatology, 2022, 19 : 280 - 280
12345